A. K. Srivastava

发表

Paper No S9.4: ESHFLCS High‐Resolution Display a Better Alternative for the IPS Displays Technology

H. S. Kwok, V. G. Chigrinov, A. K. Srivastava, 2015 .

SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4+ T Cells into CD4+FoxP3+ T Regulatory Cells by Production of IFN-γ

A. K. Srivastava, Shravan Madireddi, R. Sharma, 2012, PloS one.

CD4+ T Cells Play a Critical Role in the Generation of Primary and Memory Antitumor Immune Responses Elicited by SA-4-1BBL and TAA-Based Vaccines in Mouse Tumor Models

A. K. Srivastava, R. Sharma, E. Yolcu, 2013, PloS one.

Prime-Boost Vaccination with SA-4-1BBL Costimulatory Molecule and Survivin Eradicates Lung Carcinoma in CD8+ T and NK Cell Dependent Manner

A. K. Srivastava, R. Sharma, E. Yolcu, 2012, PloS one.

Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.

A. K. Srivastava, M. Raffeld, S. Rosenberg, 2017, The Lancet. Oncology.

Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans

A. K. Srivastava, S. Rosenberg, J. Yang, 2014, Clinical Cancer Research.

Treatment of metastatic uveal melanoma with adoptive transfer of tumor infiltrating lymphocytes: a single-center phase 2 study

A. K. Srivastava, M. Raffeld, S. Rosenberg, 2017 .

4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines.

A. K. Srivastava, Kutlu G. Elpek, Shravan Madireddi, 2010, Cancer research.